title: Latest therapeutic novelties and patents in pulmonary hypertension.
abstract: Recent advances in technology and novel pharmaceutical research findings have added new grounds in the fields of medical treatment and quality of life of patients diagnosed with pulmonary arterial hypertension (PAH). Collective assessment of new data is mandatory and useful for specialist medical doctors. This review aims to present the latest therapeutic developments of the last two years (2009-2010) in PAH. Moreover, recent patents (of the year 2010) regarding therapeutic novelties in PAH that expand treatment modalities, are hereby presented.
authors.affiliation: 1st Department of Respiratory Medicine, Medical School, Athens University, Athens Chest Diseases Hospital Sotiria, Greece. georgiahardavella@hotmail.com
authors.forename: Georgia F
authors.initials: GF
authors.lastname: Hardavella
authors.forename: Georgios S
authors.initials: GS
authors.lastname: Dionellis
authors.forename: Christina G
authors.initials: CG
authors.lastname: Kantza
authors.forename: Nikolaos G
authors.initials: NG
authors.lastname: Koulouris
authors.forename: Manos
authors.initials: M
authors.lastname: Alchanatis
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D015507:Drugs, Investigational / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D010330:Patents as Topic; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D015507:Drugs, Investigational